NCT00898508View on ClinicalTrials.gov

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

CompletedOBSERVATIONAL
Enrollment

563

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 6, 2019

Study Completion Date

June 6, 2019

Conditions
Breast Cancer
Interventions
GENETIC

gene expression analysis

GENETIC

mutation analysis

GENETIC

proteomic profiling

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

fluorescent antibody technique

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

liquid chromatography

OTHER

mass spectrometry

OTHER

medical chart review

PROCEDURE

quality-of-life assessment

Trial Locations (3)

90211

Tower Cancer Research Foundation, Beverly Hills

91105

City of Hope Medical Group, Pasadena

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00898508 - Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | Biotech Hunter | Biotech Hunter